SCHEMBL21743758

SCHEMBL21743758

c1cc2c(c(N3CCN(C4COC4)CC3)c1)CCNC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.46
CD44 P16070 2/20 0.42
CYP3A4 P08684 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
HTR1A P08908 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
PMP22 Q01453 1/20 0.41
TLR9 Q9NR96 1/20 0.41
TLR7 Q9NYK1 1/20 0.41
HTR2C P28335 4/20 0.38
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
HTR6 P50406 2/20 0.36
CYP2D6 P10635 1/20 0.36
HTR2B P41595 1/20 0.35
HTR7 P34969 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
PNMT P11086 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21743762 0.88 CD44 (0.45) CXCR4CD44CYP3A4ALDH1A1LMNA
SCHEMBL21744413 0.81 TLR9 (0.44) CD44CYP3A4MAPK1TLR9TLR7
SCHEMBL1011153 0.81 CD44 (0.49) CD44CYP3A4ALDH1A1MAPK1TLR9
SCHEMBL21744610 0.80 CD44 (0.45) CXCR4CD44TLR9TLR7HTR2C
SCHEMBL21744701 0.80 CXCR4 (0.48) CXCR4CD44CYP3A4TLR9TLR7
SCHEMBL21743767 0.80 CXCR4 (0.48) CXCR4CD44CYP3A4TLR9TLR7
SCHEMBL16485203 0.79 CD44 (0.50) CD44HTR1ATLR9TLR7HTR2C
SCHEMBL21744394 0.79 HTR2C (0.54) CD44ALDH1A1LMNAHTR1APMP22
SCHEMBL21744605 0.76 CD44 (0.46) CXCR4CD44TLR9TLR7HTR2C
SCHEMBL21744248 0.76 CD44 (0.50) CXCR4CD44TLR9TLR7HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto UNIV EMORY (US) 2023-04-13 US disclosed
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 CXCR4 1/4885CD44 407/4885CYP3A4 4527/4885
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 CXCR4 1/4885CD44 407/4885CYP3A4 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.